Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALKEM | NSE
83.50
1.53%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/03/2026
5,550.00
5,476.50
5,573.50
5,454.00
Alkem Laboratories Limited a pharmaceutical company engages in the development manufacture and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics generic drugs active pharmaceutical ingredients biosimilars and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective dermatology cardiac respiratory gastro-intestinal central nervous system oncology urology and gynaecology as well as vitamins minerals and nutrients; and pain analgesic anti-diabetic and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai India.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
High Short-term Volatility
Midcap (2B - 10B USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
27.7%1 month
36.3%3 months
25.2%6 months
20.0%35.71
33.11
6.98
0.14
0.09
25.69
5.53
-
24.36B
663.59B
7.22B
0.16
17.42
90.20
2.20
17.98
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
453.00
Range1M
586.50
Range3M
605.00
Rel. volume
0.71
Price X volume
534.73M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Limited | AUROPHARMA | Drug Manufacturers-Specialty & Generic | 1225.5 | 711.77B | 2.52% | 24.51 | 22.28% |
| Glenmark Pharmaceuticals Limited | GLENMARK | Drug Manufacturers-Specialty & Generic | 2108.9 | 595.11B | 3.39% | n/a | 15.68% |
| Laurus Labs Limited | LAURUSLABS | Drug Manufacturers-Specialty & Generic | 1045.9 | 563.91B | 1.48% | 172.16 | 62.70% |
| Ipca Laboratories Limited | IPCALAB | Drug Manufacturers-Specialty & Generic | 1500.9 | 380.78B | 1.73% | 72.46 | 22.72% |
| Ajanta Pharma Limited | AJANTPHARM | Drug Manufacturers-Specialty & Generic | 2974.9 | 376.80B | 2.01% | 47.17 | 0.99% |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | Drug Manufacturers-Specialty & Generic | 2070.4 | 321.56B | 0.91% | 51.20 | 12.92% |
| Dr. Reddy's Laboratories Limited | DRREDDY | Drug Manufacturers-Specialty & Generic | 1313.5 | 218.82B | 1.73% | 20.23 | 10.41% |
| AstraZeneca Pharma India Limited | ASTRAZEN | Drug Manufacturers-Specialty & Generic | 8601 | 215.02B | -1.15% | 197.18 | 0.65% |
| Wockhardt Limited | WOCKPHARMA | Drug Manufacturers-Specialty & Generic | 1305.2 | 200.25B | 1.15% | n/a | 70.14% |
| Eris Lifesciences Limited | ERIS | Drug Manufacturers-Specialty & Generic | 1370.2 | 186.76B | 0.89% | 48.08 | 107.55% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Hindustan Copper Limited | HINDCOPPER | Copper | 558 | 539.60B | 2.05% | 87.06 | 9.74% |
| AFFLE | AFFLE | Advertising Agencies | 1359.5 | 190.13B | -3.16% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 387.7 | 94.83B | 4.36% | 84.26 | 27.74% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 1957.7 | 69.84B | 1.56% | 120.49 | 191.28% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 41.65 | 36.54B | -2.85% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 107.41 | 15.83B | -0.11% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 232.55 | 13.63B | -1.77% | 30.54 | 80.30% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 161.41 | 5.21B | -1.23% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 69.96 | 1.93B | -0.06% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 95.5 | 1.39B | -1.90% | 35.85 | 21.78% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 25.69 | 24.85 | Par |
| Ent. to Revenue | 5.53 | 11.40 | Cheaper |
| PE Ratio | 35.71 | 51.36 | Cheaper |
| Price to Book | 6.98 | 6.83 | Par |
| Dividend Yield | 0.16 | 0.52 | Poor |
| Std. Deviation (3M) | 25.21 | 42.17 | Lower Risk |
| Debt to Equity | 0.14 | 0.35 | Cheaper |
| Debt to Assets | 0.09 | 0.17 | Cheaper |
| Market Cap | 663.59B | 290.82B | Market Leader |